1 December 2022 - The December 2022 issue of the New Zealand Pharmaceutical Schedule is now available and in effect.

There are no new/revised listings of note in the Community Schedule this month. There are a few new/revised listings in the Hospital Medicines Schedule:

• Ibrutinib (Imbruvica) - new medicine
• Meningococcal (A, C, Y and W-135) conjugate vaccine (Menactra) - restriction change
• Meningococcal (A, C, Y and W-135) conjugate vaccine (MenQuadfi) - new vaccine
• Meningococcal C conjugate vaccine (Neisvac-C) - restriction change
• Paliperidone palmitate (Invega Trinza) - new formulation
• Pneumococcal (PCV13) conjugate vaccine (Prevenar 13) - restriction change
• Tolvaptan (Jinarc) - new medicine

Read summaries of the Section H (HML) update